| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $81.36M | $70.84M | $69.56M | $209.91M | $33.92M |
| Cost of Revenue | $5.80M | $5.95M | $2.53M | $4.58M | $1.39M |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | $333.54M | $295.64M |
| R&D | $104.00M | $109.63M | $127.13M | $187.90M | $158.00M |
| SG&A | $36.56M | $41.89M | $48.42M | $72.01M | $71.46M |
| Operating Income | -$121.50M | -$130.65M | -$165.99M | -$123.63M | -$261.72M |
| Interest Expense | $16.27M | $50.21M | $46.33M | $36.92M | $18.34M |
| Tax Expense | $1.01M | $166.00K | $39.11M | $1.14M | -$21.48M |
| Net Income | -$142.62M | -$157.85M | -$240.05M | -$155.80M | -$230.03M |
| EPS (basic) | -1.1200 | -1.6200 | -2.9400 | -2.0100 | – |
| EPS (diluted) | -1.1200 | -1.6200 | -2.9400 | -2.0100 | – |
| Shares (diluted) | $127.07M | $97.16M | $81.71M | $78.15M | – |